Analysis and advice on international tax issues.
2025 · 2nd Quarter (Apr 1 - June 30)
AMGEN USA, INC.
Filed by AKIN GUMP STRAUSS HAUER & FELD.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 21, 2025
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- AKIN GUMP STRAUSS HAUER & FELD
- Client
- AMGEN USA, INC.
- Filing UUID
- 7c73d744-9148-4d73-a674-dfc1a7802ebb
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to Most Favored Nation drug pricing.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.